Technology News and Research

RSS

AMIA launches non-profit Global Health Informatics Partnership

AMIA, the U.S.-based association for informatics professionals, has launched a non-profit, wholly owned subsidiary organization called the Global Health Informatics Partnership (GHIP) to serve as an international center for collaborative initiatives on health informatics. With generous operational support from AMIA, GHIP, aims to build grassroots networks of health informatics advocates and professionals that will result in strengthened health informatics capacity in low-resource settings, primarily in South America, Africa, and Asia.

3 Sep 2010

Alcon to launch AcrySof IQ ReSTOR Multifocal Toric intraocular lens outside US during 2010 ESCRS meeting

Alcon, Inc., the world's leader in eye care and cataract surgery, announced its launch of the AcrySof® IQ ReSTOR® Multifocal Toric intraocular lens (IOL) outside the United States during the 2010 European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting in Paris, France. This new lens is built on Alcon's industry leading AcrySof® platform and is designed to provide cataract patients that have astigmatism a surgical option that delivers quality vision at all distances with increased spectacle independence.

3 Sep 2010

Researchers discover new class of edible nanostructures for energy storage

Sugar, salt, alcohol and a little serendipity led a Northwestern University research team to discover a new class of nanostructures that could be used for gas storage and food and medical technologies. And the compounds are edible.

3 Sep 2010

Celsion receives SBIR grant to develop heat sensitive liposomal technology for cancer treatment

Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".

3 Sep 2010

Scientists develop direct method to detect gene doping

Scientists at the universities in Tübingen and Mainz have developed a test that can provide conclusive proof of gene doping. "For the first time, a direct method is now available that uses conventional blood samples to detect doping via gene transfer and is still effective if the actual doping took place up to 56 days before," Professor Perikles Simon, MD, PhD from Johannes Gutenberg University Mainz, Germany explained on Thursday.

3 Sep 2010

Researchers unveil prototype model of first implantable artificial kidney

UCSF researchers today unveiled a prototype model of the first implantable artificial kidney, in a development that one day could eliminate the need for dialysis.

3 Sep 2010

Greater Cincinnati receives award to improve health care system

U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced today that the Greater Cincinnati community was awarded a $13.8 million Beacon Community cooperative agreement.

3 Sep 2010

New antibacterial peptide effective against infections in burn or blast wounds

An antibacterial peptide developed by Laszlo Otvos, a research professor of biology in Temple's College of Science and Technology, looks to be a highly-effective therapy against infections in burn or blast wounds suffered by soldiers.

2 Sep 2010

Japanese plate and screw market to grow to over $170 million by 2014

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Japanese plate and screw market will be driven by strong surgeon acceptance and adoption, driving this market to over $170 million by 2014.

2 Sep 2010

iBio and CMB enter development and marketing collaboration with GE Healthcare

iBio, Inc., its development collaborator, Fraunhofer USA Center for Molecular Biotechnology (CMB), and GE Healthcare, a unit of General Electric Company, today announced their entry into an agreement to jointly develop and globally market manufacturing solutions for biopharmaceuticals and vaccines based upon their respective proprietary technologies.

2 Sep 2010

King's College Hospital implements iMDsoft's MetaVision suite

iMDsoft® announces that King's College Hospital has gone live with iMDsoft's MetaVision® suite in its 16-bed critical care unit (PICU and HDU).

2 Sep 2010

Sigma-Aldrich Corporation announces global release of engineered mammalian cell lines

Sigma Life Science, the innovative biological products and research services business of Sigma-Aldrich Corporation, today announced the global release of a pioneering range of engineered mammalian cell lines.

2 Sep 2010

SXC Health Solutions declares nominal dividend on common shares

SXC Health Solutions Corp., a leading provider of pharmacy benefits management (PBM) services and Health Care Information Technology (HCIT) solutions to the healthcare benefits management industry, announced today that its board of directors has declared a nominal dividend on the issued and outstanding common shares of the Company to effect a two-for-one stock split.

2 Sep 2010

Marianjoy Rehabilitation receives grant for dysphagia treatment

The Tellabs Foundation has awarded Marianjoy Rehabilitation Hospital a grant of $100,000 for the Swallowing & Voice Center; one of seven centers in Marianjoy's Assistive Rehabilitation Technology Institute. The grant will meet a crucial need for Marianjoy to help treat over 1,500 individuals with dysphagia or swallowing difficulties each year.

2 Sep 2010

AspenTech 2010 fourth quarter total revenue decreases to $38.2 million

Aspen Technology, Inc., a leading provider of software and services to the process industries, today announced financial results for its fourth quarter and fiscal year 2010, ended June 30, 2010.

2 Sep 2010

Promega to provide FuGENE HD Transfection Reagent throughout life science market

Promega Corporation announces it will provide FuGENE HD Transfection Reagent throughout the life science market. The comprehensive, direct use offering from Promega means any life scientist can utilize FuGENE technology with no licensing requirements. FuGENE HD enables the transfection of DNA into many cell types with high efficiency and little-to-no toxicity.

2 Sep 2010

LifeCell, Novadaq Technologies sign exclusive sales, marketing agreement

LifeCell Corporation, a business unit of Kinetic Concepts, Inc., and Novadaq Technologies Inc. announced today the signing of an exclusive sales and marketing agreement for distribution of Novadaq's SPY Imaging System in North American surgical markets. LifeCell will drive adoption for the SPY System in breast reconstructive, head and neck, and colorectal surgical specialties, with more than half a million procedures projected annually.

2 Sep 2010

Celator Pharmaceuticals raises $20 million in Series D private equity financing

Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financing.

2 Sep 2010

InfraReDx receives 510(k) clearance to market LipiScan IVUS Coronary Imaging System

InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced that it has received 510(k) clearance from the United States Food and Drug Administration to market the LipiScan IVUS Coronary Imaging System. LipiScan IVUS is the first cardiac catheter to combine intravascular ultrasound and near-infrared spectroscopy to help cardiologists identify and characterize the plaques that complicate stenting and are associated with acute coronary events.

2 Sep 2010

Beaumont Hospital expands new multi-organ transplant program

Beaumont Hospital, Royal Oak became Michigan's third liver transplant center on Aug. 31. A 59-year-old man from Royal Oak was the first patient to receive a liver transplant through Beaumont's new multi-organ transplant program.

2 Sep 2010